PROGETTAZIONE E SVILUPPO DEL FARMACO
Module MODULO 2 FARMACOLOGIA

Academic Year 2024/2025 - Teacher: CARMELA PARENTI

Expected Learning Outcomes

At the end of the course, to pass the exam, the student must demonstrate that he/she has acquired:

 

• the terminology and basic concepts related to the tests normally performed in the preclinical screening of a new drug.

• the basic concepts and key words of the different phases of the clinical trial of a drug.

 

Course Structure

Frontal/traditional teaching

Required Prerequisites

Knowledge of basic scientific subjects: biology, human anatomy, physiology, biochemistry.

Attendance of Lessons

Mandatory

Detailed Course Content

Program

 

Preclinical studies: (2 cfu):

 • Biochemical and physiological effects of a drug and molecular mechanisms through which these effects are produced (pharmacodynamics)

-->

• In vitro and in vivo studies for the pharmacological characterization of a drug

• Concept of selectivity, affinity, efficacy and potency of a drug

• Principles of acute and chronic toxicity

• Absorption, distribution in organs, tissues and cells, metabolic transformations and pathways and methods of elimination of a drug

  • Methodologies for the pharmacokinetic characterization of a drug

 

Clinical trials (1cfu):

 

• General principles and purposes of clinical trials

• Rules of good clinical practice

• Clinical research protocols

• Phases of clinical trials

• The actors of clinical trials: participants, sponsors, contract research organizations and regulatory agencies. Ethics committees, protocol and informed consent. 

-->

Textbook Information

Recommended texts

Clementi, Fumagalli: Farmacologia generale e molecolare

Annunziato, Di Rienzo: Trattato di Farmacologia

 

Course Planning

 SubjectsText References
1 • Biochemical and physiological effects of a drug and molecular mechanisms through which these effects are produced (pharmacodynamics)• Annunziato, Di Rienzo: Trattato di Farmacologia
2In vitro and in vivo studies for the pharmacological characterization of a drugClementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia
3Concept of selectivity, affinity, efficacy and potency of a drug Annunziato, Di Rienzo: Trattato di Farmacologia
4Principles of acute and chronic toxicityClementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia
5 Absorption, distribution in organs, tissues and cells, metabolic transformations and pathways and methods of elimination of a drugAnnunziato, Di Rienzo: Trattato di Farmacologia
6Methodologies for the pharmacokinetic characterization of a drugAnnunziato, Di Rienzo: Trattato di Farmacologia
7Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia
8Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia
9Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia
10Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia
11Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia

Learning Assessment

Learning Assessment Procedures

oral exam on the contents of the program

Examples of frequently asked questions and / or exercises

How are preclinical studies related to ADME conducted?

Who is the Ethics Committee composed of and what are its functions?

How are Phase I clinical studies conducted?

What is a bias?